CTSK and periodontitis: Furthermore, CtsK has been shown to be an efficient therapeutic strategy in preclinical studies, including inflammatory, metabolic, and autoimmune diseases, such as high fat acid-induced obese mice [71], experimental periodontitis [24, 25, 72], and collagen-induced arthritis (CIA) [72].